Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
96.9M
-
Shares change
-
+49.6M
-
Total reported value, excl. options
-
$137M
-
Value change
-
+$70.1M
-
Put/Call ratio
-
4.08
-
Number of buys
-
46
-
Number of sells
-
-27
-
Price
-
$1.41
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q4 2021
98 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q4 2021.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 96.9M shares
of 237M outstanding shares and own 40.91% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (11.9M shares), Nuveen Asset Management, LLC (10.6M shares), Stonepine Capital Management, LLC (9.91M shares), VANGUARD GROUP INC (8.48M shares), BOOTHBAY FUND MANAGEMENT, LLC (8.28M shares), Magnetar Financial LLC (7.13M shares), Clearline Capital LP (6.35M shares), Velan Capital Investment Management LP (5.4M shares), AWM Investment Company, Inc. (4.58M shares), and BlackRock Inc. (4.08M shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.